Your session is about to expire
← Back to Search
Smoking Cessation Program for Quitting Smoking (tANBL Trial)
tANBL Trial Summary
This trial is testing a smoking cessation program for American Indians. The primary outcome is 7-day point prevalence abstinence from smoking cigarettes at 6 months post-baseline, with secondary outcomes including continuous abstinence and reduction in smoking at both 6 and 12 months post-baseline.
tANBL Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowtANBL Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.tANBL Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You smoke cigarettes daily.You identify as an American Indian based on your own statement.I am 18 years old or older.I have a reliable phone number for study communications.
- Group 1: Telephone All Nations Breath of Life
- Group 2: Comparison Program
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the maximum number of participants accepted for this clinical research?
"Affirmative. The clinicaltrials.gov website confirms that this experiment, which was originally posted on May 13th 2021, is currently searching for participants. 500 people are required across 1 site in order to continue the trial's progress."
Is this experiment actively seeking participants at the moment?
"Affirmative, the evidence on clinicaltrials.gov affirms that this investigation is attempting to fill its participant quota. It was initially published on May 13th 2021 and most recently modified on August 15th 2022. Five hundred individuals need to be enrolled at a single site for the trial to move forward."
Share this study with friends
Copy Link
Messenger